Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology.
Ann Surg. 2023 Sep 1;278(3):e534-e539. doi: 10.1097/SLA.0000000000005791. Epub 2023 Jan 3.
This study aimed to evaluate the association between distress at initial diagnosis and disease-free survival in patients with resectable colon cancer.
Considerable research has examined the psychological impact of having a confirmed diagnosis of cancer, but relatively limited research has examined the impact of distress during the diagnostic phase on oncological outcomes.
This is a retrospective cohort study. We included newly diagnosed colon cancer patients who had resectable surgery and underwent distress screening between July 2014 and July 2021 (N=1,362). The Korean versions of the Distress Thermometer were used to assess distress and related problems. Patients were categorized into 3 groups based on distress score: low (<4), moderate (4-7), and severe (≥8). The primary outcome was disease-free survival.
The mean distress was 5.1 (SD=2.4) and 61%, and 15% of patients had moderate and severe distress at diagnosis, respectively. The severe distress group was more likely to report fear, sadness, and concerns regarding insurance/finance, work, and childcare than the low distress group. Compared with the low distress group, the severe distress group had worse disease-free survival (Hazard Ratio=1.84, 95% CI=1.03, 3.29). The association was more evident in patients with stage IV disease (Hazard Ratio=2.53, 95% CI=1.02, 6.25).
A substantial number of patients with colon cancer experience distress at diagnosis, and severe distress has a negative impact on oncologic outcomes. Active monitoring and appropriate management of distress at diagnosis should be adopted at clinical settings.
本研究旨在评估可切除结肠癌患者初始诊断时的痛苦与无病生存之间的关系。
大量研究已经检验了确诊癌症后的心理影响,但相对较少的研究检验了诊断阶段的痛苦对肿瘤学结果的影响。
这是一项回顾性队列研究。我们纳入了 2014 年 7 月至 2021 年 7 月期间接受可切除手术且接受过痛苦筛查的新诊断结肠癌患者(N=1362)。使用韩国版痛苦温度计评估痛苦和相关问题。根据痛苦评分,患者被分为 3 组:低(<4)、中(4-7)和高(≥8)。主要结局是无病生存。
平均痛苦评分为 5.1(SD=2.4),分别有 61%和 15%的患者在诊断时出现中度和重度痛苦。与低痛苦组相比,重度痛苦组更有可能报告恐惧、悲伤以及对保险/财务、工作和儿童保育的担忧。与低痛苦组相比,重度痛苦组无病生存更差(危险比=1.84,95%CI=1.03,3.29)。该关联在 IV 期疾病患者中更为明显(危险比=2.53,95%CI=1.02,6.25)。
相当数量的结肠癌患者在诊断时会感到痛苦,重度痛苦对肿瘤学结果有负面影响。在临床实践中,应采取积极监测和适当管理诊断时的痛苦。